The launch of Cobra separator heat-treatment equipment in December positions the company for higher-volume B1 sample production in 2025. Sivaram underscored its importance in advancing toward gigawatt ...
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
NASA has presented rock and dust samples from the asteroid Bennu which exhibit some of the chemical building blocks of life.
By 2030, an increase of 78 million new jobs will emerge. To meet the demand, here are 10 essential skills to put on your resume in 2025.
We may earn a commission if you make a purchase from the links on this page. After months of leaks and rumors, the Galaxy S25 Series is finally official! Samsung’s latest flagship devices were ...
They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...
A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...
Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...
In 2019, Stanford University professor Irv Weissman and a colleague published a paper that represented a new way to target some aggressive cancers.
Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback